 Clinical predictors buserelin acetate treatment uterine fibroids prospective study women Buserelin acetate hormone-releasing hormone agonist effective shrinkage uterine fibroids prospective trial efficacy intranasal IN subcutaneous SC administration buserelin acetate tumor regression fibroid size and/or patient age patients months IN buserelin acetate SC buserelin acetate patients study statistical analysis Fibroid regression patients Overall regression initial fibroid volume subjects significant difference fibroid shrinkage administration routes significant positive correlation initial fibroid size subsequent fibroid regression tumors likely fibroids correlation patient age extent fibroid regression